menu
    • menu
    [{"orgOrder":0,"company":"Illimis Therapeutics","sponsor":"DSC Investment","pharmaFlowCategory":"D","therapeuticArea":"Neurology","country":"SOUTH KOREA","productType":"Protein","year":"2025","type":"Series B Financing","leadProduct":"ILM01","moa":"Amyloid-beta","graph1":"Neurology","graph2":"Discovery","graph3":"Illimis Therapeutics","amount2":0.040000000000000001,"highestDevelopmentShortName":"Discovery","therapeuticAreaShortName":"Neurology","amount2New":0.040000000000000001,"dosageForm":"Undisclosed","sponsorNew":"Illimis Therapeutics \/ DSC Investment","highestDevelopmentStatusID":"2","companyTruncated":"Illimis Therapeutics \/ DSC Investment"}]

    Find Clinical Drug Pipeline Developments & Deals by Illimis Therapeutics

    Menu

    Illimis Therapeutics

    EVENTS

    • Webinars & Exhibitions

    DIGITAL CONTENT

    DEVELOPMENTS

    PharmaCompass
    Xls
    Filters Filter
    ×
    FILTER:
    filter
    Company Name
      filter

      Year

        filter

        DEALS // DEV.

          filter

          Country

            filter
            Sponsor
              filter

              Therapeutic Area

                filter

                Study Phase

                  filter

                  Deal Type

                    filter

                    Product Type

                      filter

                      Dosage Form

                        filter

                        Lead Product

                          filter

                          Target

                            Loading...
                            refresh Filters
                            refresh Reset Filter
                            refresh Reset Filter
                            price-trend All Developments

                            Therapeutic Area by Lead Product

                            Study Phase by Lead Product

                            Company by Lead Product

                            Top Deals by Deal Size (USD bn)

                            01

                            Illimis Therapeutics

                            South Korea arrow
                            AGGSpend
                            Not Confirmed

                            Illimis Therapeutics

                            South Korea arrow
                            AGGSpend
                            Not Confirmed
                            • fda
                            • EDQM
                            • WHO-GMP
                            Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

                            Lead Product(s) : ILM01

                            Therapeutic Area : Neurology

                            Study Phase : Discovery

                            Sponsor : DSC Investment

                            Deal Size : $42.0 million

                            Deal Type : Series B Financing

                            DEALS_DEV arrow-down

                            Illimis Therapeutics Closes 58 billion KRW ($42 million) Series B Financing

                            Details : The funds will be used to accelerate Alzheimer's and immune disease drug development, expanding GAIA-based pipeline, including ILM01.

                            Product Name : ILM01

                            Product Type : Protein

                            Upfront Cash : Undisclosed

                            July 14, 2025

                            Lead Product(s) : ILM01

                            Therapeutic Area : Neurology

                            Highest Development Status : Discovery

                            Sponsor : DSC Investment

                            Deal Size : $42.0 million

                            Deal Type : Series B Financing

                            blank

                            Stock Recap
                            #PipelineProspector

                            Data Compilation
                            #PharmaFlow

                            Virtual Booth